NSE Symbol: | BSE Code: | ISIN: | Sector:
| Change | Change % |
| -0.70 | -1.09% |
Updated:02 Feb, 2023, 15:57 PM IST |
|
| Change | Change % |
| -0.70 | -1.09% |
Updated:02 Feb, 2023, 16:01 PM IST |
|
No Records Found!
No Records Found!
Statement Of Investor Complaints For The Quarter Ended June 2018
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disp...
Marksans Pharma Limited has submitted to the Exchange, the financial results for the period ended March 31, 2018.
Marksans Pharma Limited has informed the Exchange that Board of Directors at its meeting held on May 30, 2018, recommended Final Dividend of 0.05 per ...
Marksans Pharma Limited has informed the Exchange regarding a press release dated May 30, 2018, titled "Press Release".
Board Meeting-Closure of Trading Window
This is to inform you that the Meeting of the Board of Directors of the Company will be held on Wednesday, 30th May, 2018 at Mumbai, to consider and a...
Board Meeting - Board Meeting On Wednesday, 30Th May, 2018
This is to inform you that the Meeting of the Board of Directors of the Company will be held on Wednesday, 30th May, 2018 at Mumbai, to consider and a...
Shareholding for the Period Ended March 31, 2018
Marksans Pharma Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2018. For more details, kindly Click here
Regulation 40 (9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
Regulation 40 (9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Dear Sir, With reference to above captioned subject, pl...
Compliance Certificate For The Period Ended 31.03.2018
Reg. 7(3) RTA Compliance Certificate for the period ended 31.03.2018
Statement Of Investor Complaints For The Quarter Ended March 2018
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disp...
Announcement under Regulation 30 (LODR)-Change in Directorate
Appointment of Mr. Digant Mahesh Parikh as Independent Director
Marksans Pharma Limited has informed the Exchange regarding Appointment of Mr Digant Mahesh Parikh as Independent Director of the company w.e.f. March...
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press Release dated 12.02.2018
Board Meeting-Outcome of Board Meeting
Sub: Unaudited Financial Results for the quarter ended 31st December, 2017 and Limited Review Reports thereon. Dear Sir, In terms of Regulation 33 of ...
Marksans Pharma Limited has informed the Exchange regarding a press release dated February 12, 2018, titled "Press Release ".
Marksans Pharma Limited has submitted to the Exchange, the financial results for the period ended December 31, 2017.
Marksans Pharma Limited has informed the Exchange regarding Outcome of Board Meeting held on February 12, 2018.
Marksans Pharma Limited has informed the Exchange regarding 'Dividend Distribution Policy of the Company approved and adopted by the Board of Director...
Shareholding for the Period Ended December 31, 2017
Marksans Pharma Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2017. For more details, kindly Click here
Statement Of Investor Complaints For The Quarter Ended December, 2017
Statement of Investor Complaints for the quarter ended December, 2017 under Regulation 13(3) of SEBI (LODR), 2015.
Market Dashboard